Combination of discharge algorithm and trypsinogen-2 urine dipstick to safely discharge patients after endoscopic retrograde cholangiopancreatography (ERCP)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22334

Enrollment

260

Registered

2020-03-30

Start date

2018-08-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-ERCP pancreatitis

Interventions

Urine dipstick 2 hours after scope-mouth contact of ERCP + patient reported experience measurement at day of discharge

Eligibility

Inclusion criteria

Inclusion criteria: - Patients undergoing ERCP - Age >18 years

Exclusion criteria

Exclusion criteria: - Ongoing acute pancreatitis

Design outcomes

Primary

Measure	Time frame
Asses the sensitivity and specificity of an ERCP discharge tool that combines a discharge algorithm and urinary trypsinogen-2 dipstick.	—

Secondary

Measure	Time frame
1) Endoscopist and patient attitudes (measured by PREM questionnaire) towards discharge tool combined with urinary dipstick testing. 2) Identification of factors that lead to false positives and negatives of the trypsinogen-2 urinary dipstick. 3) Overall cost reduction obtained by safe early discharge.	—

Contacts

Public ContactChrista Sperna Weiland

Radboudumc

christa.spernaweiland@radboudumc.nl0883207054

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)